REFLECT: prospective multicenter non-interventional study evaluating the effectiveness and safety of Sandoz rituximab (SDZ-RTX; Rixathon®) in combination with CHOP for the treatment of patients with previously untreated CD20-positive diffuse large B-cell lymphoma
Welslau, Manfred, Kubuschok, Boris, Topaly, Julian, Otremba, Burkhard, Wolff, Thomas, Bryn, Galyna
Published in Therapeutic advances in hematology (01.01.2023)
Published in Therapeutic advances in hematology (01.01.2023)
Get full text
Journal Article